Skip to main content

Amgen gets FDA approval for its inflammatory diseases treatment Wezlana

By MarketWatch  
   November 01, 2023

Amgen AMGN has received approval from the FDA for Wezlana, its treatment for multiple inflammatory diseases.

Full story


Get the latest on healthcare leadership in your inbox.